-The Hindu Business Line New Delhi: India has raised serious concerns over a proposed US legislation that will require agriculture imports to be mandatorily inspected and audited by the US Food and Drug Administration (USFDA). New Delhi fears that once the law is implemented — in about a year from now — it will raise costs for Indian exporters sharply, making exports unfeasible in many cases. Commerce Minister Nirmala Sitharaman is expected to...
More »SEARCH RESULT
Total Matching Records found : 9358
Anicut and after... -Preeti Mehra
-The Hindu Business Line One small check dam helps stem migration in Khohar, Haryana Every year, nearly all the 150 households of village Khohar, in Haryana’s Mewat district, pack their bags in September and embark on a journey to Gujarat. Hired to pick cotton, they spend the next 4-5 months in pitched tents, working from dawn to dusk. “We return with around ₹50,000 earned between everyone in the family. This sees us through...
More »Seized pulses to be in market in 2-4 weeks -Dipak K Dash
-The Times of India NEW DELHI: States may have seized around 78,000 tonnes of pulses in raids till Monday, but it is taking time to release this huge quantity in the market to moderate the spiraling prices. This is because the officials need to follow the norms laid down in the Essential Commodities Act, which may take at least two to four weeks from the date of seizure. On Monday, arhar was...
More »RTI still has miles to go -Haider Abbas
-The Indian Express There are certain issues, however, which need be addressed, to make sure that the information commission becomes fully autonomous and thus becomes a constitutional body. Celebrations for 10 years of democratic transparency, in the form of the Right to Information Act, are going on. What we have achieved as yet and what is still someway to go needs to be found out. The many scams, which have successfully helped...
More »Scientifically validated Rs 5 anti-diabetes herbal drug launched by CSIR -Neha Shukla
-The Times of India LUCKNOW: A scientifically validated anti-diabetes herbal drug, named 'BGR-34', was launched by a Council of Scientific and Industrial Research (CSIR) lab in Lucknow on Sunday. A combination of natural extracts from plants, the drug is based on Ayurveda and has no side effects. The drug is for management of type-II diabetes mellitus. The drug has been jointly developed by two CSIR laboratories, National Botanical Research Institute (NBRI) and...
More »
